Next Generation News and Research

RSS

First-in-humans study introduces next generation cell therapy for heart failure patients

Translating a Mayo Clinic stem-cell discovery, an international team has demonstrated that therapy with cardiopoietic (cardiogenically-instructed) or "smart" stem cells can improve heart health for people suffering from heart failure.

11 Apr 2013

MedeAnalytics' Accountable Care Solution selected for Mississippi's MEHRS application

MedeAnalytics, a leading provider of healthcare performance management solutions, announced today that the State of Mississippi Medicaid has selected MedeAnalytics' Accountable Care Solution to empower the next generation of the state's Medicaid Electronic Health Records System application.

9 Apr 2013

Experts outline challenges, opportunities of using social media in clinical care setting

As social media drastically alters the world we live in, physicians are left wondering what their role is in the digital revolution. In the first comprehensive review of its kind, experts at the George Washington University School of Medicine and Health Sciences have outlined the challenges and opportunities of using social media in a clinical care setting.

9 Apr 2013

Mammalian target of rapamycin (mTOR) pathway: an interview with Dr. Paul Mischel, Ludwig Institute for Cancer Research

The mammalian target of rapamycin, mTOR is a central integrator of the cell that coordinates growth factor receptor signaling with energy and nutrient status to control a wide array of activities, including the regulation of cellular proliferation and survival.

9 Apr 2013

Viewpoints: Drugging soldiers; GOP opposition to Medicaid expansion strays from party legacy; Health law distorts market

Last year, more active-duty soldiers committed suicide than died in battle. ... Worse, according to data not reported on until now, the military evidently responded to stress that afflicts soldiers in Iraq and Afghanistan primarily by drugging soldiers on the front lines.

9 Apr 2013

GE Healthcare releases next-generation sequencing assay for use in clinical trials

GE Healthcare announced today that Clarient Diagnostic Services, Inc., a GE Healthcare company, will begin offering a next-generation sequencing assay focused on solid tumor targets for use in clinical trials.

8 Apr 2013

Lipocine announces favorable Phase I study results for LPCN 1111

Lipocine Inc., a biopharmaceutical company focused on developing innovative oral hormone therapies for men's and women's health, today announced favorable Phase I results for LPCN 1111.

8 Apr 2013

Sorrento Therapeutics, IGDRASOL to present updates on Cynviloq at Nanomedicine 2013 meeting

Sorrento Therapeutics, Inc. and IGDRASOL announced today that IGDRASOL will be presenting updates of its analysis of proprietary late clinical stage NBN-Pac formulations, namely IG-001 (Cynviloq) and IG-004 (a D-a-tocopheryl polyethylene glycol succinate (TPGS)-based paclitaxel formulation) at the annual Nanomedicine 2013 meeting in Barcelona, Spain (April 11th - 12th).

8 Apr 2013

A*STAR's professor receives Szent-Gy-rgyi prize for groundbreaking cancer pill

Professor Alex Matter, Chief Executive Officer of A*STAR's Experimental Therapeutics Centre (ETC), has been awarded the 8th Annual Szent-Gy-rgyi Prize for Progress in Cancer Research by the National Foundation for Cancer Research (NFCR) for his contributions to the development of the first drug specifically targeting a molecular lesion in cancer.

7 Apr 2013

Individualized genomic analysis allows for tailored cancer treatment, new drug research

Just like a massive iceberg jutting out of the ocean, many of cancer's genetic underpinnings remain hidden under the surface, impossible to predict or map from above.

6 Apr 2013

FDA approves InVivo Therapeutics' IDE to test biopolymer scaffold product in humans

InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries and other neurotrauma conditions, today announced that the U.S. Food and Drug Administration has approved the Company's Investigational Device Exemption to begin human studies to test its biopolymer scaffold product, a technology developed to treat patients with acute, traumatic SCI.

5 Apr 2013

UIC College of Pharmacy receives grant to train students in natural product drugs

Elizabeth Martinez hopes to one day discover a cure for menopausal symptoms using an herbal dietary supplement. With the help of a new federal training grant to the University of Illinois at Chicago College of Pharmacy, her vision may become reality.

5 Apr 2013

FDA approves CryoLife's next generation HeRO device

CryoLife, Inc., a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that it has received U.S. Food and Drug Administration 510(k) clearance for a next generation HeRO (Hemodialysis Reliable Outflow) device.

5 Apr 2013

Promising step toward safer, more comfortable implants

Researchers led by scientists at Case Western Reserve University have turned to an unlikely model to make medical devices safer and more comfortable-a squid's beak.

4 Apr 2013

Illumina releases TruSight Tumor for NGS-based somatic variant detection in solid tumors

Illumina, Inc. today announced the next product in its TruSight line of content sets, TruSight Tumor, for NGS-based somatic variant detection in solid tumors.

From Illumina, Inc. 4 Apr 2013

Scientists develop new cancer immunotherapy treatment for children with high-risk solid tumors

Recently, research using adoptive T-cell immunotherapy in blood cancers have shown success, most notably in the case of a seven-year-old girl whose leukemia went into remission using altered T-cells and a disabled HIV virus.

4 Apr 2013

UCLA Children's Discovery and Innovation Institute to drive research on children's health

For more than 60 years, the faculty and staff at Mattel Children's Hospital UCLA and the department of pediatrics at the David Geffen School of Medicine at UCLA have conducted pioneering research, delivered state-of-the-art patient care and expertly trained future pediatricians.

4 Apr 2013

Three institutions partner to create research breakthroughs in children's health

Virginia Tech, Children's National Medical Center, and the George Washington University have partnered in a unique program to create research breakthroughs in children's health.

4 Apr 2013

TGen to present scientific benefits of whole genome sequencing at myeloma workshop

The scientific benefits of whole genome sequencing at the Translational Genomics Research Institute will be presented at the 14th International Myeloma Workshop, April 3-7 at the Kyoto International Conference Center.

4 Apr 2013

FDA clears LENSAR Laser System to perform corneal, arcuate incisions during cataract surgery

LENSAR Inc., developer of the next generation LENSAR Laser System™ for refractive cataract surgery, announced today that the company's laser system has received 510(k) clearance from the United States Food and Drug Administration for the execution of arcuate incisions during cataract surgery.

3 Apr 2013

Next Generation News and Research

First-in-humans study introduces next generation cell therapy for heart failure patients

MedeAnalytics' Accountable Care Solution selected for Mississippi's MEHRS application

Experts outline challenges, opportunities of using social media in clinical care setting

Mammalian target of rapamycin (mTOR) pathway: an interview with Dr. Paul Mischel, Ludwig Institute for Cancer Research

Viewpoints: Drugging soldiers; GOP opposition to Medicaid expansion strays from party legacy; Health law distorts market

GE Healthcare releases next-generation sequencing assay for use in clinical trials

Lipocine announces favorable Phase I study results for LPCN 1111

Sorrento Therapeutics, IGDRASOL to present updates on Cynviloq at Nanomedicine 2013 meeting

A*STAR's professor receives Szent-Gy-rgyi prize for groundbreaking cancer pill

Individualized genomic analysis allows for tailored cancer treatment, new drug research

FDA approves InVivo Therapeutics' IDE to test biopolymer scaffold product in humans

UIC College of Pharmacy receives grant to train students in natural product drugs

FDA approves CryoLife's next generation HeRO device

Promising step toward safer, more comfortable implants

Illumina releases TruSight Tumor for NGS-based somatic variant detection in solid tumors

Scientists develop new cancer immunotherapy treatment for children with high-risk solid tumors

UCLA Children's Discovery and Innovation Institute to drive research on children's health

Three institutions partner to create research breakthroughs in children's health

TGen to present scientific benefits of whole genome sequencing at myeloma workshop

FDA clears LENSAR Laser System to perform corneal, arcuate incisions during cataract surgery

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News